{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T14:38:47Z","timestamp":1776523127375,"version":"3.51.2"},"reference-count":114,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":1793,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Nutrition"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.3945\/an.116.013730","type":"journal-article","created":{"date-parts":[[2017,3,15]],"date-time":"2017-03-15T12:45:54Z","timestamp":1489581954000},"page":"253-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Nutritional Approaches to Achieve Weight Loss in Nonalcoholic Fatty Liver Disease"],"prefix":"10.1016","volume":"8","author":[{"given":"Christine C","family":"Hsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Ness","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kris V","family":"Kowdley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3945\/an.116.013730_bib1","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology","volume":"142","author":"Chalasani","year":"2012","journal-title":"Gastroenterology"},{"key":"10.3945\/an.116.013730_bib2","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"key":"10.3945\/an.116.013730_bib3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/hep.20543","article-title":"Chronological development of elevated aminotransferases in a nonalcoholic population","volume":"41","author":"Suzuki","year":"2005","journal-title":"Hepatology"},{"key":"10.3945\/an.116.013730_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.7861\/clinmedicine.7-2-119","article-title":"Hepatology outpatient service provision in secondary care: a study of liver disease incidence and resource costs","volume":"7","author":"Whalley","year":"2007","journal-title":"Clin Med (Lond)"},{"key":"10.3945\/an.116.013730_bib5","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.cld.2009.07.005","article-title":"Epidemiology and natural history of non-alcoholic steatohepatitis","volume":"13","author":"Argo","year":"2009","journal-title":"Clin Liver Dis"},{"key":"10.3945\/an.116.013730_bib6","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"key":"10.3945\/an.116.013730_bib7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MD.0b013e3182779d49","article-title":"Nonalcoholic fatty liver disease in lean individuals in the United States","volume":"91","author":"Younossi","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"10.3945\/an.116.013730_bib8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/MEG.0b013e32832fcdf0","article-title":"Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain","volume":"22","author":"Caballer\u00eda","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.3945\/an.116.013730_bib9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hep.20734","article-title":"Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study","volume":"42","author":"Bedogni","year":"2005","journal-title":"Hepatology"},{"key":"10.3945\/an.116.013730_bib10","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s00535-003-1178-8","article-title":"Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background","volume":"38","author":"Kojima","year":"2003","journal-title":"J Gastroenterol"},{"key":"10.3945\/an.116.013730_bib11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1665-2681(19)31922-2","article-title":"Prevalence of non-alcoholic fatty liver disease: population based study","volume":"6","author":"Amarapurkar","year":"2007","journal-title":"Ann Hepatol"},{"key":"10.3945\/an.116.013730_bib12","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.3945\/an.116.013730_bib13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2174\/1574887109666141216111143","article-title":"Non alcoholic fatty liver: epidemiology and natural history","volume":"9","author":"Masarone","year":"2014","journal-title":"Rev Recent Clin Trials"},{"key":"10.3945\/an.116.013730_bib14","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/hep.510300604","article-title":"Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis","volume":"30","author":"Angulo","year":"1999","journal-title":"Hepatology"},{"key":"10.3945\/an.116.013730_bib15","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0016-5085(00)70364-7","article-title":"Liver fibrosis in overweight patients","volume":"118","author":"Ratziu","year":"2000","journal-title":"Gastroenterology"},{"key":"10.3945\/an.116.013730_bib16","first-page":"377","article-title":"Prevalence and risk factors of fatty liver disease in Chengdu, Southwest China","volume":"8","author":"Li","year":"2009","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.3945\/an.116.013730_bib17","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1440-1746.2005.04086.x","article-title":"Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults","volume":"21","author":"Park","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"10.3945\/an.116.013730_bib18","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1159\/000235677","article-title":"Non-alcoholic fatty liver disease in older people","volume":"55","author":"Frith","year":"2009","journal-title":"Gerontology"},{"key":"10.3945\/an.116.013730_bib19","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/j.1440-1746.2006.04615.x","article-title":"Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan","volume":"22","author":"Chen","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.3945\/an.116.013730_bib20","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1572-0241.2003.07486.x","article-title":"The prevalence and etiology of elevated aminotransferase levels in the United States","volume":"98","author":"Clark","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.3945\/an.116.013730_bib21","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1007\/s10620-008-0234-x","article-title":"Ethnicity and nonalcoholic fatty liver disease in an obesity clinic: the impact of triglycerides","volume":"53","author":"Kallwitz","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.3945\/an.116.013730_bib22","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study","volume":"140","author":"Williams","year":"2011","journal-title":"Gastroenterology"},{"key":"10.3945\/an.116.013730_bib23","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.cgh.2009.06.007","article-title":"Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Hossain","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.3945\/an.116.013730_bib24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1478-3231.2008.01718.x","article-title":"Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus","volume":"29","author":"Leite","year":"2009","journal-title":"Liver Int"},{"key":"10.3945\/an.116.013730_bib25","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1381\/0960892055002347","article-title":"Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass","volume":"15","author":"Boza","year":"2005","journal-title":"Obes Surg"},{"key":"10.3945\/an.116.013730_bib26","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/archsurg.138.11.1240","article-title":"Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery","volume":"138","author":"Beymer","year":"2003","journal-title":"Arch Surg"},{"key":"10.3945\/an.116.013730_bib27","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/hep.20323","article-title":"Portal fibrosis and hepatic steatosis in morbidly obese subjects: a spectrum of nonalcoholic fatty liver disease","volume":"40","author":"Abrams","year":"2004","journal-title":"Hepatology"},{"key":"10.3945\/an.116.013730_bib28","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000087295","article-title":"Non-alcoholic fatty liver disease in young adult severely obese non-diabetic patients in South Italy","volume":"49","author":"Colicchio","year":"2005","journal-title":"Ann Nutr Metab"},{"key":"10.3945\/an.116.013730_bib29","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jhep.2006.06.013","article-title":"Hepatic histology in obese patients undergoing bariatric surgery","volume":"45","author":"Machado","year":"2006","journal-title":"J Hepatol"},{"key":"10.3945\/an.116.013730_bib30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: a population-based cohort study","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology"},{"key":"10.3945\/an.116.013730_bib31","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"Ekstedt","year":"2006","journal-title":"Hepatology"},{"key":"10.3945\/an.116.013730_bib32","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1111\/j.1572-0241.2008.02034.x","article-title":"Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study","volume":"103","author":"Dunn","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.3945\/an.116.013730_bib33","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cgh.2008.11.005","article-title":"Long-term follow-up of patients with nonalcoholic fatty liver","volume":"7","author":"Rafiq","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.3945\/an.116.013730_bib34","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/hep.23314","article-title":"Decreased survival of subjects with elevated liver function tests during a 28-year follow-up","volume":"51","author":"S\u00f6derberg","year":"2010","journal-title":"Hepatology"},{"key":"10.3945\/an.116.013730_bib35","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"key":"10.3945\/an.116.013730_bib36","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"Singh","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.3945\/an.116.013730_bib37","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J Clin Invest"},{"key":"10.3945\/an.116.013730_bib38","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1053\/j.gastro.2007.11.038","article-title":"Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease","volume":"134","author":"Fabbrini","year":"2008","journal-title":"Gastroenterology"},{"key":"10.3945\/an.116.013730_bib39","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/hep.28392","article-title":"Diet, weight loss, and liver health in nonalcoholic fatty liver disease: pathophysiology, evidence, and practice","volume":"63","author":"Marchesini","year":"2016","journal-title":"Hepatology"},{"key":"10.3945\/an.116.013730_bib40","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/01.mog.0000182863.96421.47","article-title":"Role of inflammation in nonalcoholic steatohepatitis","volume":"21","author":"Choi","year":"2005","journal-title":"Curr Opin Gastroenterol"},{"key":"10.3945\/an.116.013730_bib41","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.1440-1746.2007.05212.x","article-title":"Visceral adipose tissue area is an independent risk factor for hepatic steatosis","volume":"23","author":"Park","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"10.3945\/an.116.013730_bib42","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.cld.2009.07.012","article-title":"Non-alcoholic fatty liver disease: is bariatric surgery the answer?","volume":"13","author":"Pillai","year":"2009","journal-title":"Clin Liver Dis"},{"key":"10.3945\/an.116.013730_bib43","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2174\/1389450033490920","article-title":"Insulin resistance as a proinflammatory state: mechanisms, mediators, and therapeutic interventions","volume":"4","author":"Garg","year":"2003","journal-title":"Curr Drug Targets"},{"key":"10.3945\/an.116.013730_bib44","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1056\/NEJMoa033179","article-title":"Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease","volume":"350","author":"Klein","year":"2004","journal-title":"N Engl J Med"},{"key":"10.3945\/an.116.013730_bib45","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/hep.22575","article-title":"Orlistat for overweight subjects with nonalcoholic steatohepatitis: a randomized, prospective trial","volume":"49","author":"Harrison","year":"2009","journal-title":"Hepatology"},{"key":"10.3945\/an.116.013730_bib46","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hep.23276","article-title":"Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis","volume":"51","author":"Promrat","year":"2010","journal-title":"Hepatology"},{"key":"10.3945\/an.116.013730_bib47","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jhep.2013.04.013","article-title":"Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial","volume":"59","author":"Wong","year":"2013","journal-title":"J Hepatol"},{"key":"10.3945\/an.116.013730_bib48","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"key":"10.3945\/an.116.013730_bib49","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1038\/oby.2007.261","article-title":"High dietary sodium intake increases white adipose tissue mass and plasma leptin in rats","volume":"15","author":"Fonseca-Alaniz","year":"2007","journal-title":"Obesity (Silver Spring)"},{"key":"10.3945\/an.116.013730_bib50","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1194\/jlr.M800418-JLR200","article-title":"Effect of dietary monosodium glutamate on trans fat-induced nonalcoholic fatty liver disease","volume":"50","author":"Collison","year":"2009","journal-title":"J Lipid Res"},{"key":"10.3945\/an.116.013730_bib51","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1017\/S0007114516003391","article-title":"Dietary sodium and potassium intake in relation to non-alcoholic fatty liver disease","volume":"116","author":"Choi","year":"2016","journal-title":"Br J Nutr"},{"key":"10.3945\/an.116.013730_bib52","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.3390\/nu7064778","article-title":"Dietary patterns modulate the risk of non-alcoholic fatty liver disease in Chinese adults","volume":"7","author":"Yang","year":"2015","journal-title":"Nutrients"},{"key":"10.3945\/an.116.013730_bib53","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/liv.12990","article-title":"The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: a randomized clinical trial","volume":"36","author":"Razavi Zade","year":"2016","journal-title":"Liver Int"},{"key":"10.3945\/an.116.013730_bib54","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1080\/09637486.2016.1210101","article-title":"Adherence to the dietary approaches to stop hypertension (DASH) and risk of nonalcoholic fatty liver disease","volume":"67","author":"Hekmatdoost","year":"2016","journal-title":"Int J Food Sci Nutr"},{"key":"10.3945\/an.116.013730_bib55","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.nut.2012.12.018","article-title":"Effects of dietary approaches to stop hypertension (DASH)-style diet on fatal or nonfatal cardiovascular diseases-incidence: a systematic review and meta-analysis on observational prospective studies","volume":"29","author":"Salehi-Abargouei","year":"2013","journal-title":"Nutrition"},{"key":"10.3945\/an.116.013730_bib56","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S1665-2681(19)31176-7","article-title":"Combined high-fat diet and sustained high sucrose consumption promotes NAFLD in a murine model","volume":"14","author":"Torres-Villalobos","year":"2015","journal-title":"Ann Hepatol"},{"key":"10.3945\/an.116.013730_bib57","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/hep.23797","article-title":"High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis","volume":"52","author":"Kohli","year":"2010","journal-title":"Hepatology"},{"key":"10.3945\/an.116.013730_bib58","doi-asserted-by":"crossref","first-page":"G987","DOI":"10.1152\/ajpgi.90272.2008","article-title":"Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent","volume":"295","author":"Tetri","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.3945\/an.116.013730_bib59","first-page":"109","article-title":"Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction","volume":"4","author":"Basaranoglu","year":"2015","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.3945\/an.116.013730_bib60","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jhep.2008.02.011","article-title":"Fructose consumption as a risk factor for non-alcoholic fatty liver disease","volume":"48","author":"Ouyang","year":"2008","journal-title":"J Hepatol"},{"key":"10.3945\/an.116.013730_bib61","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1053\/gast.2001.23256","article-title":"Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities","volume":"120","author":"Sanyal","year":"2001","journal-title":"Gastroenterology"},{"key":"10.3945\/an.116.013730_bib62","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.jhep.2008.01.035","article-title":"Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin","volume":"48","author":"Bergheim","year":"2008","journal-title":"J Hepatol"},{"key":"10.3945\/an.116.013730_bib63","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/hep.23122","article-title":"Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice","volume":"50","author":"Spruss","year":"2009","journal-title":"Hepatology"},{"key":"10.3945\/an.116.013730_bib64","doi-asserted-by":"crossref","first-page":"560620","DOI":"10.1155\/2014\/560620","article-title":"Fructose induced endotoxemia in pediatric nonalcoholic Fatty liver disease","volume":"2014","author":"Jin","year":"2014","journal-title":"Int J Hepatol"},{"key":"10.3945\/an.116.013730_bib65","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/hep.22848","article-title":"Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease","volume":"49","author":"Miele","year":"2009","journal-title":"Hepatology"},{"key":"10.3945\/an.116.013730_bib66","doi-asserted-by":"crossref","first-page":"G518","DOI":"10.1152\/ajpgi.00024.2006","article-title":"Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis","volume":"292","author":"Brun","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.3945\/an.116.013730_bib67","doi-asserted-by":"crossref","first-page":"G433","DOI":"10.1152\/ajpgi.00163.2009","article-title":"Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice","volume":"300","author":"Csak","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"Suppl 1","key":"10.3945\/an.116.013730_bib68","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/jgh.12019","article-title":"Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis","volume":"28","author":"Roh","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"10.3945\/an.116.013730_bib69","doi-asserted-by":"crossref","first-page":"e80169","DOI":"10.1371\/journal.pone.0080169","article-title":"Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice","volume":"9","author":"Ritze","year":"2014","journal-title":"PLoS One"},{"key":"10.3945\/an.116.013730_bib70","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jnutbio.2012.01.014","article-title":"Lactobacillus casei Shirota protects from fructose-induced liver steatosis: a mouse model","volume":"24","author":"Wagnerberger","year":"2013","journal-title":"J Nutr Biochem"},{"key":"10.3945\/an.116.013730_bib71","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1743-7075-10-35","article-title":"Oral administration of Lactobacillus reuteri GMNL-263 improves insulin resistance and ameliorates hepatic steatosis in high fructose-fed rats","volume":"10","author":"Hsieh","year":"2013","journal-title":"Nutr Metab (Lond)"},{"key":"10.3945\/an.116.013730_bib72","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/hep.23535","article-title":"Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease","volume":"51","author":"Abdelmalek","year":"2010","journal-title":"Hepatology"},{"key":"10.3945\/an.116.013730_bib73","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/ejcn.2014.8","article-title":"Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials","volume":"68","author":"Chiu","year":"2014","journal-title":"Eur J Clin Nutr"},{"key":"10.3945\/an.116.013730_bib74","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.3390\/nu6083187","article-title":"Dietary fructose reduction improves markers of cardiovascular disease risk in Hispanic-American adolescents with NAFLD","volume":"6","author":"Jin","year":"2014","journal-title":"Nutrients"},{"key":"10.3945\/an.116.013730_bib75","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S1665-2681(19)31517-0","article-title":"Decrease of aminotransferase levels in obese women is related to body weight reduction, irrespective of type of diet","volume":"10","author":"Rodr\u00edguez-Hern\u00e1ndez","year":"2011","journal-title":"Ann Hepatol"},{"key":"10.3945\/an.116.013730_bib76","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/hep.24242","article-title":"Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects","volume":"53","author":"Haufe","year":"2011","journal-title":"Hepatology"},{"key":"10.3945\/an.116.013730_bib77","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.2337\/dc06-2169","article-title":"Serum alanine aminotransferase levels decrease further with carbohydrate than fat restriction in insulin-resistant adults","volume":"30","author":"Ryan","year":"2007","journal-title":"Diabetes Care"},{"key":"10.3945\/an.116.013730_bib78","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s10620-006-9433-5","article-title":"The effect of a low-carbohydrate, ketogenic diet on nonalcoholic fatty liver disease: a pilot study","volume":"52","author":"Tendler","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.3945\/an.116.013730_bib79","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3945\/ajcn.2010.29673","article-title":"Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis","volume":"92","author":"Sofi","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.3945\/an.116.013730_bib80","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jhep.2013.02.012","article-title":"The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease","volume":"59","author":"Ryan","year":"2013","journal-title":"J Hepatol"},{"key":"10.3945\/an.116.013730_bib81","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12876-016-0426-3","article-title":"A randomised controlled trial of a Mediterranean Dietary Intervention for Adults with Non Alcoholic Fatty Liver Disease (MEDINA): study protocol","volume":"16","author":"Papamiltiadous","year":"2016","journal-title":"BMC Gastroenterol"},{"key":"10.3945\/an.116.013730_bib82","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.clnu.2013.08.014","article-title":"Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease","volume":"33","author":"Kontogianni","year":"2014","journal-title":"Clin Nutr"},{"key":"10.3945\/an.116.013730_bib83","article-title":"An extra virgin olive oil-rich diet intervention ameliorates the non-alcoholic steatohepatitis induced by a high-fat \u201cWestern type\u201d diet in mice","author":"Jurado-Ruiz","year":"2016","journal-title":"Mol Nutr Food Res"},{"issue":"8","key":"10.3945\/an.116.013730_bib84","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3945\/jn.112.158865","article-title":"Menhaden oil decreases high-fat diet-induced markers of hepatic damage, steatosis, inflammation, and fibrosis in obese Ldlr\u2212\/\u2212 mice","volume":"142","author":"Depner","year":"2012","journal-title":"J Nutr"},{"key":"10.3945\/an.116.013730_bib85","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3945\/jn.112.171322","article-title":"Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr\u2212\/\u2212 mouse model of western diet-induced nonalcoholic steatohepatitis","volume":"143","author":"Depner","year":"2013","journal-title":"J Nutr"},{"key":"10.3945\/an.116.013730_bib86","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.bbadis.2013.02.003","article-title":"Prevention and reversal of hepatic steatosis with a high-protein diet in mice","volume":"1832","author":"Garcia-Caraballo","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.3945\/an.116.013730_bib87","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1017\/S000711451500238X","article-title":"High dietary protein decreases fat deposition induced by high-fat and high-sucrose diet in rats","volume":"114","author":"Chaumontet","year":"2015","journal-title":"Br J Nutr"},{"key":"10.3945\/an.116.013730_bib88","article-title":"Isocaloric diets high in animal or plant protein reduce liver fat and inflammation in individuals with type 2 diabetes","author":"Markova","year":"2016","journal-title":"Gastroenterology"},{"key":"10.3945\/an.116.013730_bib89","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jhep.2010.05.018","article-title":"Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride","volume":"53","author":"Li","year":"2010","journal-title":"J Hepatol"},{"key":"10.3945\/an.116.013730_bib90","doi-asserted-by":"crossref","first-page":"e24895","DOI":"10.1371\/journal.pone.0024895","article-title":"Circulating fibroblast growth factor 21 levels are closely associated with hepatic fat content: a cross-sectional study","volume":"6","author":"Yan","year":"2011","journal-title":"PLoS One"},{"key":"10.3945\/an.116.013730_bib91","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.1038\/ctg.2016.28","article-title":"Short-term hypocaloric high-fiber and high-protein diet improves hepatic steatosis assessed by controlled attenuation parameter","volume":"7","author":"Arslanow","year":"2016","journal-title":"Clin Transl Gastroenterol"},{"key":"10.3945\/an.116.013730_bib92","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3945\/an.114.007716","article-title":"Controversies surrounding high-protein diet intake: satiating effect and kidney and bone health","volume":"6","author":"Cuenca-Sanchez","year":"2015","journal-title":"Adv Nutr"},{"key":"10.3945\/an.116.013730_bib93","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3945\/jn.115.228148","article-title":"Dietary broccoli lessens development of fatty liver and liver cancer in mice given diethylnitrosamine and fed a western or control diet","volume":"146","author":"Chen","year":"2016","journal-title":"J Nutr"},{"key":"10.3945\/an.116.013730_bib94","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jff.2016.03.028","article-title":"Dietary broccoli protects against fatty liver development but not against progression of liver cancer in mice pretreated with diethylnitrosamine","volume":"24","author":"Chen","year":"2016","journal-title":"J Funct Foods"},{"key":"10.3945\/an.116.013730_bib95","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3109\/09637486.2016.1161011","article-title":"Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study","volume":"67","author":"Yari","year":"2016","journal-title":"Int J Food Sci Nutr"},{"key":"10.3945\/an.116.013730_bib96","doi-asserted-by":"crossref","first-page":"e34897","DOI":"10.5812\/hepatmon.34897","article-title":"Ginger supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study","volume":"16","author":"Rahimlou","year":"2016","journal-title":"Hepat Mon"},{"key":"10.3945\/an.116.013730_bib97","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4103\/2008-7802.173051","article-title":"The effect of green tea extract supplementation on liver enzymes in patients with nonalcoholic fatty liver disease","volume":"7","author":"Pezeshki","year":"2016","journal-title":"Int J Prev Med"},{"key":"10.3945\/an.116.013730_bib98","first-page":"236","article-title":"Gastrointestinal surgery for severe obesity: a response","volume":"41","author":"Marcus","year":"1992","journal-title":"Md Med J"},{"key":"10.3945\/an.116.013730_bib99","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1053\/j.gastro.2007.03.057","article-title":"Bariatric surgery: a review of procedures and outcomes","volume":"132","author":"Elder","year":"2007","journal-title":"Gastroenterology"},{"key":"10.3945\/an.116.013730_bib100","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJMoa066254","article-title":"Effects of bariatric surgery on mortality in Swedish obese subjects","volume":"357","author":"Sj\u00f6strom","year":"2007","journal-title":"N Engl J Med"},{"key":"10.3945\/an.116.013730_bib101","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1056\/NEJMoa1112082","article-title":"Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects","volume":"367","author":"Carlsson","year":"2012","journal-title":"N Engl J Med"},{"key":"10.3945\/an.116.013730_bib102","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJMoa066603","article-title":"Long-term mortality after gastric bypass surgery","volume":"357","author":"Adams","year":"2007","journal-title":"N Engl J Med"},{"key":"10.3945\/an.116.013730_bib103","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/jamasurg.2014.3515","article-title":"Clarification of the goals of the national institutes of health symposium on bariatric surgery outcomes","volume":"150","author":"Courcoulas","year":"2015","journal-title":"JAMA Surg"},{"key":"10.3945\/an.116.013730_bib104","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1381\/0960892055002239","article-title":"Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity","volume":"15","author":"Stratopoulos","year":"2005","journal-title":"Obes Surg"},{"key":"10.3945\/an.116.013730_bib105","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/01.sla.0000179652.07502.3f","article-title":"Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome","volume":"242","author":"Mattar","year":"2005","journal-title":"Ann Surg"},{"key":"10.3945\/an.116.013730_bib106","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/oby.2005.140","article-title":"Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease","volume":"13","author":"Clark","year":"2005","journal-title":"Obes Res"},{"key":"10.3945\/an.116.013730_bib107","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1053\/j.gastro.2006.01.042","article-title":"Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease","volume":"130","author":"Klein","year":"2006","journal-title":"Gastroenterology"},{"key":"10.3945\/an.116.013730_bib108","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1053\/j.gastro.2015.04.014","article-title":"Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients","volume":"149","author":"Lassailly","year":"2015","journal-title":"Gastroenterology"},{"key":"10.3945\/an.116.013730_bib109","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.cgh.2008.08.012","article-title":"Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"6","author":"Mummadi","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.3945\/an.116.013730_bib110","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.pcl.2009.07.002","article-title":"Nutritional deficiencies in obesity and after bariatric surgery","volume":"56","author":"Xanthakos","year":"2009","journal-title":"Pediatr Clin North Am"},{"key":"10.3945\/an.116.013730_bib111","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3945\/an.113.004341","article-title":"Mineral malnutrition following bariatric surgery","volume":"4","author":"Gletsu-Miller","year":"2013","journal-title":"Adv Nutr"},{"key":"10.3945\/an.116.013730_bib112","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1177\/000313480607201209","article-title":"Incidence of vitamin deficiency after laparoscopic Roux-en-Y gastric bypass in a university hospital setting","volume":"72","author":"Clements","year":"2006","journal-title":"Am Surg"},{"key":"10.3945\/an.116.013730_bib113","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1001\/jamasurg.2014.3579","article-title":"Five-year outcomes after laparoscopic gastric bypass and laparoscopic duodenal switch in patients with body mass index of 50 to 60: a randomized clinical trial","volume":"150","author":"Risstad","year":"2015","journal-title":"JAMA Surg"},{"key":"10.3945\/an.116.013730_bib114","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3945\/ajcn.2009.27583","article-title":"Vitamin status after bariatric surgery: a randomized study of gastric bypass and duodenal switch","volume":"90","author":"Aasheim","year":"2009","journal-title":"Am J Clin Nutr"}],"container-title":["Advances in Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2161831322007153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2161831322007153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3945\/an.116.013730","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T01:07:50Z","timestamp":1761872870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2161831322007153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":114,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S2161831322007153"],"URL":"https:\/\/doi.org\/10.3945\/an.116.013730","relation":{},"ISSN":["2161-8313"],"issn-type":[{"value":"2161-8313","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nutritional Approaches to Achieve Weight Loss in Nonalcoholic Fatty Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Advances in Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3945\/an.116.013730","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Society for Nutrition","name":"copyright","label":"Copyright"}]}}